Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
36.25
+1.09 (3.10%)
At close: Jul 3, 2025, 1:00 PM
36.25
0.00 (0.00%)
After-hours: Jul 3, 2025, 1:01 PM EDT

Monopar Therapeutics Market Cap

Monopar Therapeutics has a market cap or net worth of $221.68 million as of July 3, 2025. Its market cap has increased by 1,248.80% in one year.

Market Cap
221.68M
Enterprise Value
167.12M
1-Year Change
1,248.80%
Ranking
Category
Stock Price
$36.25

Market Cap Chart

Since December 19, 2019, Monopar Therapeutics's market cap has decreased from $276.16M to $221.68M, a decrease of -19.73%. That is a compound annual growth rate of -3.89%.

History

DateMarket Cap% Change
Jul 2, 2025215.01M60.26%
Dec 31, 2024134.17M2,552.79%
Dec 29, 20235.06M-83.48%
Dec 30, 202230.62M-24.23%
Dec 31, 202140.42M-42.33%
Dec 31, 202070.09M-59.48%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 697.81B
Johnson & Johnson 374.26B
AbbVie 337.65B
Novo Nordisk 306.99B
UnitedHealth Group 283.79B
Novartis AG 242.04B
Abbott Laboratories 234.03B
AstraZeneca 221.11B
Market Cap Rankings